Product News
PerkinElmer To Acquire Cell Engineering Company Horizon Research
PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Horizon Discovery Group plc (LSE: HZD) have announced an agreed investment to be used for advancing their life sciences and genomics technology departments.
Product News
Thermo Fisher Scientific Extends Collaboration to Advance Biopharmaceutical Discovery and Development
Thermo Fisher Scientific and Symphogen announce the extension of a strategic collaboration to deliver quality control workflows for the simplified analysis of complex therapeutic proteins and advance biopharmaceutical discovery and development.
Product News
CN Bio Announces Commercial Launch of Its Metabolism and Safety Toxicity Testing Services
CN Bio today announced the commercial launch of its Drug Metabolism and Safety Toxicity Testing Services. The new toxicity testing services also provide researchers with additional support and bandwidth during the COVID-19 pandemic, when laboratories are not at full capacity.
Product News
Researchers Tackle the Surface Transmission of COVID-19 in New Partnership
A project to develop surface treatments that can provide long-lasting protection against the COVID-19 virus has been launched at the University of Birmingham.
Product News
AMSBIO Launches New Human iPSC-Derived Cells and iPSC Differentiation Reagent Kits
AMSBIO is launching a new range of human iPSC-derived cells and human iPSC differentiation reagent kits optimized for high-throughput experiments in areas including drug discovery and toxicity screening.
Product News
AMSBIO Announces StemFit® for Mesenchymal Stem Cells
AMSBIO announces StemFit® for MSC - a new and optimized medium for expansion and maintenance of Mesenchymal Stem Cells.
Product News
Long-Acting Peptide Therapy for Heart Failure To Be Developed by AL-Protein and Bioscience
Antlia Bioscience, Inc., and XL-protein GmbH are pleased to announce a strategic slliance using XL-protein's proprietary PASylation® technology for plasma half-life extension to develop a novel, long-acting, peptide therapeutic treatment for chronic heart failure.
Product News
Iksuda Therapeutics Enters Agreement With University of Goettingen To Develop Novel Antibody Drug Conjugates
Iksuda Therapeutics (Iksuda), today announces it has executed its option to secure exclusive, worldwide rights to develop a novel class of tumour-activated prodrug payloads from the University of Goettingen, following a successful collaboration exemplifying the series in ADC formats.
Product News
Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells
Axol Bioscience (Axol), a biotechnology company specializing in the use of stem cell technology, today announced the expansion of its service offering, with the introduction of multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells.
Product News
Mogrify Introduces EpiMOGRIFY To Identify Epigenetic Switches
Mogrify Limited (Mogrify®) today announced the introduction of EpiMOGRIFY. The platform models the epigenetic state of the cell to predict the switches important for cell identity, cell maintenance, directed differentiation and cell conversion.
Advertisement